| Last price paid | n.a. | |
| Change | -7.18% [ -0.15 ] | |
| Last traded volume | n.a. Unit | |
| Cumulative volume | n.a. Unit | |
| Date/time | n.a. n.a. | |
| Initial fixing date | 30.04.2025 |
| Settlement date | 08.05.2025 |
| Last trading | 18.12.2026 |
| Final fixing | 18.12.2026 |
| Currency redemption | CHF |
| Perf. since issue | +545.45% |
| Year to date (YTD) | +162.16% |
| 1 month | +83.02% |
| 3 months | +234.48% |
| 1 year | n.a. |
| 3 years | n.a. |
| Issue price | 0.33 |
| Underlying price on issue | 93.69 |
| Premium | 0.01% |
| Premium p.a. | 0.01% |
| Leverage | 5.14 |
| Implied volatility | 0.22 |
| ISIN | CH1446463841 |
| Symbol | NOV1CZ |
| Security | 144646384 |
| Exchange | SIX Structured Products |
| Currency | CHF |
| Expiry | 29.12.2026 |
| Underlying | Novartis N, CH0012005267 |
| Underlying ISIN | CH0012005267 |
| Strike | 110.00 |
| C/P type | call |
| Subscription ratio | 10.00 |
| Issuer | Zuercher Kantonalbank |
| Exercise type | American |
| Delivery of securities | On Demand |
| Minimum execution | 10 |
| Value day | 30.04.2025 |
| Premium | 0.69% |
| Premium p.a. | 0.83% |
| Leverage | 6.12 |
| Implied volatility | 22.16% |
| Moneyness | in-the-money |
| Leverage | 5.1431 |
| Delta | 0.7643 |
| Gamma | 0.0015 |
| Theta | -0.0005 |
| Rho | 0.0301 |
| Vega | 0.0253 |
| Fair value | 0.09 |
| Intrinsic value | n.a. |
| Break-even | 131.30 |
| SSPA value at risk | n.a. |
| SSPA risk rating | n.a. |
| SSPA derivative category | Leverage |
| SSPA code | Warrant (2100) |
| Name | Price |
|---|---|
| KUEHNE & NAGEL | 187.25 |
| SWISSCOM N | 671.50 |
| ZURICH INSURANCE | 570.80 |
| Alcon AG | 60.32 |
| Swiss Re | 132.30 |